QS should be available for women in the United States.

Reason for the survey: To gather evidence to gain FDA approval for QS permanent contraception for women a safe and 98% effective method.

Why should I take this survey: To help U.S. women who wish to have no more children end their fertility without surgery.

How long will this survey take: Approximately 15 minutes.

How will I be compensated: Please specify and/or 501(C)3 nonprofit ISAF will email you a letter thanking you for your donation.

Background:

Watch a video (use the back button to return) and read about this safe and 98% effective non-drug in-office method.

The QS procedure – is a nonsurgical permanent contraceptive method for women.  Using an intrauterine device (IUD) inserter a trained healthcare provider puts 7 tiny (36mg) quinacrine pellets into the uterus without need for general anesthesia twice. The 1st dose is given after a period ends. The 2nd dose is given one month later. The patient can return to work after each 15-minute visit and must keep using their old birth control method for the next 3 months while an immune response to the quinacrine pellets permanently blocks both fallopian tubes 98% of the time (not 99% like having your tubes tied). Blockage can be verified by ultrasound.  This method is safe and has been used by more than 200,000 women in over 50 countries with minimal side effects lasting a day or less.  Our book of clinical trials on Amazon and free here shows:

 

Begin the Survey:

What is your gender?

Please check the single box that describes you best.

I routinely use ICD-10-CM Diagnosis Code Z30.430 "Encounter for insertion of intrauterine contraceptive device."

I spend greater than 60% of my time in direct patient care.

I provide sexual & reproductive health care in-office to greater than 10% of my patients.

Would you recommend QS permanent contraception to your patients if it was FDA approved?

Would the lower cost of QS compared to other methods positively influence your decision?

Would you like to participate in QS permanent contraception FDA clinical trials?